Spots Global Cancer Trial Database for tumor
Every month we try and update this database with for tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders | NCT01387971 | Pterygium Dry Eye Tumor | 12 Years - 85 Years | National Taiwan University Hospital | ||
| Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State | NCT01930006 | Advanced Malign... | MGCD265 | 18 Years - 55 Years | Mirati Therapeutics Inc. | |
| Study of Apatinib as an Inhibitor of Tumor Angiogenesis | NCT00633490 | Tumor | apatinib | 18 Years - 70 Years | Fudan University | |
| Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer | NCT01416038 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | DPX-Survivac low dose cyclop... | 18 Years - | ImmunoVaccine Technologies, Inc. (IMV Inc.) | |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH) | NCT01903967 | Pituitary Tumor... | 18 Years - 85 Years | Hospices Civils de Lyon | ||
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects | NCT05740475 | Pulmonary Fibro... Tumor | 9MW3811 injecti... Placebo | 18 Years - 55 Years | Mabwell (Shanghai) Bioscience Co., Ltd. | |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | NCT02440685 | Lymphoma, Large... Lymphoma, Mantl... Lymphoma, Folli... Cancer Neoplasm Tumor Lymphoma, Malig... Lymphoma, B-cel... Lymphoma, Non-H... B-Cell Chronic ... B-Cell Leukemia... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Lymph... Leukemia, Lymph... Myelofibrosis Chronic Idiopat... Idiopathic Myel... Lymphoma, T Cel... Peripheral T-Ce... T-Cell Lymphoma... | ASN002 Dose Esc... ASN002 RD | 18 Years - | Asana BioSciences | |
| Pharmacokinetic, Safety and Tolerability Study of SPARC1028 | NCT01305512 | Solid Tumor in ... | SPARC1028 | 18 Years - | Sun Pharma Advanced Research Company Limited | |
| S100B in Intensive Care Patients With and Without Traumatic Brain Injury | NCT04501315 | Tumor Brain Injuries Trauma Injury Critical Illnes... Surgery--Compli... | Blood, cerebros... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions | NCT03214835 | Laryngeal Disea... Laryngeal Tumor Laryngopharynge... | Endo CDx Brush ... | 18 Years - | CDx Diagnostics | |
| The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative Study | NCT05397522 | Bone Cancer Tumor | Supervised Exer... Supervised Exer... | 18 Years - 65 Years | Istanbul Medeniyet University | |
| Radiation Therapy and Cardiac Enzymes | NCT00777751 | Tumor | 18 Years - | M.D. Anderson Cancer Center | ||
| Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination | NCT01304303 | Solid Tumor in ... | SPARC1023 I SPARC1023 II | 18 Years - | Sun Pharma Advanced Research Company Limited | |
| CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions | NCT03214835 | Laryngeal Disea... Laryngeal Tumor Laryngopharynge... | Endo CDx Brush ... | 18 Years - | CDx Diagnostics | |
| A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) | NCT01090765 | Prostate Cancer Metastatic Cast... | TRC105 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors. | NCT05203601 | Tumor | SIBP-03 | 18 Years - 75 Years | Shanghai Institute Of Biological Products | |
| Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | NCT02852564 | Bladder Cancer | Ethacrynic Acid | 18 Years - | University of Kansas Medical Center | |
| Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma | NCT05470283 | Tumor Metastatic Mela... Melanoma | OBX-115 Acetazolamide Cyclophosphamid... Furosemide Mesna Fludarabine Pho... | 18 Years - | M.D. Anderson Cancer Center | |
| Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer | NCT03542877 | Colorectal Canc... | Oral Tablet: Ca... | 18 Years - 99 Years | University of Colorado, Denver | |
| Gadobutrol Magnevist-controlled Body Study | NCT01050829 | Magnetic Resona... | Gadobutrol (Gad... Gadopentetate D... | 20 Years - | Bayer | |
| Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer | NCT00806156 | Tumor Ovarian Cancer | NKTR-102 q14d NKTR-102 q21d | 18 Years - | Nektar Therapeutics | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma | NCT01703481 | Tumor or Lympho... | JNJ-42756493: P... JNJ-42756493: P... JNJ-42756493: P... JNJ-42756493: P... | 18 Years - | Janssen Research & Development, LLC | |
| The Effects of High-flow Nasal Oxygen on Oxygenation During Rigid Bronchoscopy Under General Anesthesia in Pediatric Patients | NCT03905733 | Foreign Bodies Tumor Stenosis of Tra... Bronchus | Optiflow | - 7 Years | Yonsei University | |
| Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | NCT00356122 | Non-Small Cell ... | Docetaxel Oxaliplatin Bevacizumab | 18 Years - | Sanofi | |
| A Phase II Study of Anlotinib in MTC Patients | NCT01874873 | Tumor | Anlotinib | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures | NCT01238666 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| Phase I Dose Escalating Study of TKI258 | NCT01471548 | Advanced Solid ... | TKI258 | 20 Years - | Novartis | |
| Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma | NCT01480479 | Glioblastoma Small Cell Glio... Giant Cell Glio... Gliosarcoma Glioblastoma Wi... | Rindopepimut (C... Temozolomide KLH | 18 Years - | Celldex Therapeutics | |
| Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer | NCT01848431 | Open Fracture o... Tumor | 18 Years - | University of Zurich | ||
| A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors | NCT05108623 | Tumor, Solid | agenT-797 Approved ICIs | 18 Years - | MiNK Therapeutics | |
| Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer | NCT00802945 | Tumor Breast Cancer | NKTR-102 NKTR-102 | 18 Years - | Nektar Therapeutics | |
| Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors | NCT02134067 | Advanced Solid ... | TAS-119 Paclitaxel | 18 Years - | Taiho Oncology, Inc. | |
| Varian ProBeam Proton Therapy System China Clinical Trial (Guangzhou) | NCT06338436 | Tumor, Solid | Proton Radiatio... | 18 Years - 80 Years | Varian, a Siemens Healthineers Company | |
| ASPREE Cancer Endpoints Study | NCT01968798 | Cancer | Aspirin Placebo | 65 Years - | Hennepin Healthcare Research Institute | |
| Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) | NCT03986034 | Chronic Lymphoc... | During Venetocl... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors | NCT04417465 | Advanced Solid ... | ABBV-CLS-579 PD-1 inhibitor VEGFR TKI | 18 Years - | Calico Life Sciences LLC | |
| A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors | NCT05108623 | Tumor, Solid | agenT-797 Approved ICIs | 18 Years - | MiNK Therapeutics | |
| Esthesioneuroblastoma: Outcomes After Treatment | NCT02580136 | Esthesioneurobl... | 10 Years - 80 Years | Ohio State University | ||
| Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study | NCT05879146 | Tumor | Nirogacestat | 18 Years - | M.D. Anderson Cancer Center | |
| Natural History of Patients With Brain and Spinal Cord Tumors | NCT00009035 | Astrocytoma Oligodendroglio... Glioblastoma Glioma Anaplastic Glio... | 1 Year - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis | NCT00355745 | Breast Cancer | Ultrasound brea... | 21 Years - 70 Years | Helix Medical Systems | |
| Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome | NCT00089765 | Von Hippel-Lind... | Ranibizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial | NCT03454282 | Breast Cancer Melanoma, Malig... | FMD | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy | NCT03619356 | Hypoxia Oxygen Deficien... Tumor Diabetes | 20 Years - | National Taiwan University Hospital | ||
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors | NCT04106492 | Cancer | SQ3370 | 18 Years - | Shasqi, Inc. | |
| HemosprayTM for Gastrointestinal Bleeding From Cancer | NCT03855904 | Gastrointestina... | TC-325 | 18 Years - | King Chulalongkorn Memorial Hospital | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System | NCT00726128 | Trauma Tumor Pseudarthrosis Scoliosis Degenerative Di... | VueLock™ Anteri... | - | Zimmer Biomet | |
| Ceramide NanoLiposome in Patients With Advanced Solid Tumors | NCT02834611 | Cancer Carcinoma Solid Tumors Tumor | Ceramide NanoLi... | 18 Years - | Keystone Nano, Inc | |
| Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | NCT00356122 | Non-Small Cell ... | Docetaxel Oxaliplatin Bevacizumab | 18 Years - | Sanofi | |
| 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG | NCT05543317 | Tumor, Solid Positron-Emissi... | 18F-FDG PET/CT,... | 18 Years - 90 Years | The First Affiliated Hospital of Xiamen University | |
| A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease | NCT01024036 | Multicentric Ca... | Siltuximab Placebo Best Supportive... | 18 Years - | Janssen Research & Development, LLC | |
| A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) | NCT01226901 | Neoplasms Solid Tumors | MK-4827 | 18 Years - | Merck Sharp & Dohme LLC | |
| Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only | NCT00950911 | Bone Metastases... Bone Metastases... Bone Metastases... | amg 162 | 18 Years - | Amgen | |
| Prospective Use of Philips iSuite for Interventional Procedures | NCT03432936 | Cancer Tumor | MRI guided proc... | 18 Years - 90 Years | Mayo Clinic | |
| Diffusion MRI-1 Imaging Database | NCT03775694 | Epilepsy Tumor Healthy Other | dMRI Scan | - | Medtronic Spinal and Biologics | |
| A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | NCT00795301 | Rectal Cancer | Capecitabine, C... | 21 Years - | National University Hospital, Singapore | |
| Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma | NCT01473095 | Solid Tumor Malignant Lymph... Tumor | ARQ 092 | 18 Years - | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | |
| Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer | NCT02250326 | Carcinoma, Non-... | nab-paclitaxel ... CC-486 Duravalumab | 18 Years - | Celgene | |
| The Effect of Anesthetic Technique on VEGF-C and PGE2 | NCT02829333 | Uterine Leiomyo... | general anesthe... spinal anesthes... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| Study of Apatinib as an Inhibitor of Tumor Angiogenesis | NCT00633490 | Tumor | apatinib | 18 Years - 70 Years | Fudan University | |
| Consequences on the Gait Pattern of Patients With Distal Femur Megaprostheses | NCT06282198 | Distal Femoral ... | 16 Years - 99 Years | Cardenal Herrera University | ||
| Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases | NCT04001725 | Brain Metastase... Melanoma Lung Cancer Breast Cancer | Dexamethasone Metformin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Varian ProBeam Proton Therapy System Clinical Trial (Shandong) | NCT06340815 | Tumor, Solid | Radiation: Prot... | 18 Years - 80 Years | Varian, a Siemens Healthineers Company | |
| EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | NCT00035100 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | epothilone b | 18 Years - | Novartis | |
| Autologous TLPO Vaccine Basket | NCT06175221 | Tumor, Solid Tumor Metastasi... Cancer Tumor | Tumor lysate, p... | 18 Years - | Elios Therapeutics, LLC | |
| Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology | NCT06417190 | Muscle-Invasive... Tumor | Trimodal therap... | 18 Years - | Cedars-Sinai Medical Center | |
| The Impact of Ureteral Stents on Peristalsis | NCT01739738 | Kidney Stones Tumor Hydronephrosis | Ureteral Stent | 19 Years - | University of British Columbia | |
| Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms | NCT04509167 | Neoplasms | Neoantigen Pept... | 16 Years - 70 Years | Instituto de Medicina Regenerativa | |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols | NCT00035373 | Glioblatoma Gliosarcoma Anaplastic Astr... Oligodendroglio... Anaplastic Olig... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut | NCT00171873 | Neuroendocrine ... | Octreotide LAR ... Placebo | 18 Years - | Philipps University Marburg Medical Center | |
| Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors | NCT00660426 | Advanced Gastro... Solid Tumors | Oxaliplatin Gemcitabine Capecitabine | 18 Years - | Washington University School of Medicine | |
| Utility of Primary Glioblastoma Cell Lines | NCT04180046 | Tumor Brain Tumor | - | Neuromed IRCCS | ||
| A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors | NCT05781555 | Malignant Tumor | Experimental: D... | 18 Years - | Alpha Tau Medical LTD. | |
| Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG | NCT03695757 | Immunotherapy | Part A) Healthy... Part B) Advance... | 19 Years - | Ajou University School of Medicine | |
| Tissue Characterization With Hyperspectral Imaging (HSI) | NCT04230603 | Tissue Perfusio... Tumor Inflammation Inflammatory Bo... | Hyperspectral i... Lactate acid me... pathological ex... | 18 Years - | University of Leipzig | |
| Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis | NCT04310410 | Bone Metastases Bone Neoplasm Bone Lesion Bone Cancer Pain Cancer Induced ... Radiation Toxic... Quality of Life Tumor Neoplasm Metast... | combined radiot... | 18 Years - | UMC Utrecht | |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | NCT00363051 | Islet Cell Carc... Neuroendocrine ... Neuroendocrine ... Pancreatic Neop... | Everolimus 10 m... Octreotide Depo... | 18 Years - | Novartis | |
| Development of Early Detection Signs for Gastrointestinal Cancer | NCT00633334 | GI Cancer | Specimen bank | 18 Years - | University of Pittsburgh |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
